(Q46984034)

English

Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients

scientific article published on 30 October 2013

Statements

Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit